| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1029340778 |
| P356 | DOI | 10.1007/S11897-012-0113-9 |
| P8608 | Fatcat ID | release_ynf66nwcjjbzjk7amz7wbazyle |
| P698 | PubMed publication ID | 22961192 |
| P2093 | author name string | Kai C Wollert | |
| Tibor Kempf | |||
| P2860 | cites work | MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily | Q24317134 |
| A gene atlas of the mouse and human protein-encoding transcriptomes | Q24568043 | ||
| Aging-associated cardiovascular changes and their relationship to heart failure | Q27024178 | ||
| Latent TGF-β structure and activation | Q27670456 | ||
| Use of natriuretic peptides to guide and monitor heart failure therapy | Q27692530 | ||
| Use of a continuous-flow device in patients awaiting heart transplantation | Q28244009 | ||
| Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury | Q28251154 | ||
| Biomarkers in heart failure | Q28280109 | ||
| Cardiac myocyte gene expression profiling during H2O2-induced apoptosis | Q28568243 | ||
| The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury | Q33231048 | ||
| GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells | Q33891553 | ||
| Identification of follistatin-like 1 by expression cloning as an activator of the growth differentiation factor 15 gene and a prognostic biomarker in acute coronary syndrome | Q34032238 | ||
| Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality | Q34072831 | ||
| Telomere dysfunction induces metabolic and mitochondrial compromise. | Q34163637 | ||
| Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association | Q34172244 | ||
| The p53 network: cellular and systemic DNA damage responses in aging and cancer | Q34248711 | ||
| Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence | Q34286746 | ||
| The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction | Q34343385 | ||
| National patterns of risk-standardized mortality and readmission for acute myocardial infarction and heart failure. Update on publicly reported outcomes measures based on the 2010 release | Q34522451 | ||
| Desmoglein 2 mutant mice develop cardiac fibrosis and dilation. | Q35017328 | ||
| Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study | Q35021094 | ||
| Effects of continuous-flow versus pulsatile-flow left ventricular assist devices on myocardial unloading and remodeling | Q35228339 | ||
| The role of mRNA decay in p53-induced gene expression | Q35567490 | ||
| Diabetes and the risk of heart failure | Q35571144 | ||
| The renal transcriptome of db/db mice identifies putative urinary biomarker proteins in patients with type 2 diabetes: a pilot study | Q35924547 | ||
| Variability of N-terminal probrain natriuretic peptide in stable chronic heart failure and its relation to changes in clinical variables | Q48696688 | ||
| Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction | Q48788412 | ||
| Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism. | Q53436137 | ||
| GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. | Q54623768 | ||
| Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non ST-Elevation Acute Coronary Syndrome | Q56593478 | ||
| p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload | Q57396501 | ||
| Prognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart Failure | Q57422717 | ||
| The Relationship between Insulin Resistance and the Cardiovascular Biomarker Growth Differentiation Factor-15 in Obese Patients | Q58788278 | ||
| GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice | Q58807888 | ||
| Antiangiogenic Activity of the MDM2 Antagonist Nutlin-3 | Q58905267 | ||
| The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy | Q60992399 | ||
| Growth Differentiation Factor-15: Induction in Liver Injury Through p53 and Tumor Necrosis Factor-Independent Mechanisms1 | Q63322960 | ||
| Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study | Q74387491 | ||
| Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction | Q81541774 | ||
| Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome | Q82921408 | ||
| Tailored therapy for heart failure: the role of biomarkers | Q84179057 | ||
| A crucial role for adipose tissue p53 in the regulation of insulin resistance | Q84491291 | ||
| Connecting obesity, aging and diabetes | Q84522378 | ||
| Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22 | Q85239091 | ||
| In search of new therapeutic targets and strategies for heart failure: recent advances in basic science | Q36364300 | ||
| Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study | Q36851584 | ||
| GDF15 triggers homeostatic proliferation of acid-secreting collecting duct cells | Q36906059 | ||
| Telomeres and mitochondria in the aging heart | Q37033248 | ||
| Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology | Q37090971 | ||
| PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway | Q37143062 | ||
| Anemia and chronic heart failure implications and treatment options. | Q37237844 | ||
| Cardiorenal syndrome | Q37324890 | ||
| Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy | Q37420336 | ||
| Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome | Q37463255 | ||
| Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas Heart Study | Q37588805 | ||
| Is oxidative stress a therapeutic target in cardiovascular disease? | Q37803047 | ||
| Emerging biomarkers in heart failure | Q37956614 | ||
| Pressure overload | Q37959774 | ||
| Growth differentiation factor 15 acts anti-apoptotic and pro-hypertrophic in adult cardiomyocytes | Q38345677 | ||
| p53-induced adipose tissue inflammation is critically involved in the development of insulin resistance in heart failure | Q39416345 | ||
| Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial | Q39564409 | ||
| Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial. | Q39835614 | ||
| Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study | Q39916498 | ||
| Growth-differentiation factor-15 in heart failure | Q39960475 | ||
| Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study | Q39967372 | ||
| A p53-type response element in the GDF15 promoter confers high specificity for p53 activation | Q40175015 | ||
| Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay | Q40257914 | ||
| The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide | Q40408743 | ||
| Macrophage inhibitory cytokine-1: a novel biomarker for p53 pathway activation | Q40623007 | ||
| Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1. | Q40722521 | ||
| The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-beta superfamily member, acts as a quality control determinant for correctly folded MIC-1. | Q40749068 | ||
| Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression | Q40884700 | ||
| Profile of gene expression regulated by induced p53: connection to the TGF-beta family | Q40893077 | ||
| Exercise limitation in chronic heart failure: central role of the periphery | Q41187847 | ||
| Deficiency of liver sinusoidal scavenger receptors stabilin-1 and -2 in mice causes glomerulofibrotic nephropathy via impaired hepatic clearance of noxious blood factors. | Q41939161 | ||
| Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis | Q42288906 | ||
| Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3. | Q42507061 | ||
| Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes | Q42805165 | ||
| Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome | Q43715189 | ||
| Relation of growth-differentiation factor 15 to left ventricular remodeling in ST-segment elevation myocardial infarction. | Q43983466 | ||
| Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension | Q44226730 | ||
| Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions | Q45086910 | ||
| Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy | Q45263389 | ||
| Clustering of 37 circulating biomarkers by exploratory factor analysis in patients following complicated acute myocardial infarction. | Q45906534 | ||
| Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet. | Q45974276 | ||
| The haplotype of the growth-differentiation factor 15 gene is associated with left ventricular hypertrophy in human essential hypertension. | Q45978322 | ||
| Influence of postprandial triglyceride-rich lipoproteins on lipid-mediated gene expression in smooth muscle cells of the human coronary artery | Q46527093 | ||
| Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specific gene program | Q46833890 | ||
| Reference change values and determinants of variability of NT-proANP and GDF15 in stable chronic heart failure | Q48034834 | ||
| B-type natriuretic peptide in cardiovascular disease | Q48237778 | ||
| P433 | issue | 4 | |
| P921 | main subject | heart failure | Q181754 |
| P304 | page(s) | 337-345 | |
| P577 | publication date | 2012-12-01 | |
| P1433 | published in | Current heart failure reports | Q26842297 |
| P1476 | title | Growth differentiation factor 15 in heart failure: an update | |
| P478 | volume | 9 |
| Q52768529 | Acute effects of moderate altitude on biomarkers of cardiovascular inflammation and endothelial function and their differential modulation by dual endothelin receptor blockade. |
| Q38671285 | Association of Growth Differentiation Factor 15 with Mortality in a Prospective Hemodialysis Cohort |
| Q97545233 | Associations Between Cardiac Biomarkers and Cardiac Structure and Function in CKD |
| Q92727802 | Biomarkers in patients with heart failure and central sleep apnoea: findings from the SERVE-HF trial |
| Q95582601 | Cardiac Biomarkers and Risk of Incident Heart Failure in Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study |
| Q37344271 | Concise review: growth differentiation factor 15 in pathology: a clinical role? |
| Q36621007 | Effect of Atorvastatin on Growth Differentiation Factor-15 in Patients with Type 2 Diabetes Mellitus and Dyslipidemia. |
| Q40340848 | Effect of genetic and environmental factors on protein biomarkers for common non-communicable disease and use of personally normalized plasma protein profiles (PNPPP). |
| Q34836097 | Emerging biomarkers in heart failure and cardiac cachexia |
| Q26798142 | GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective |
| Q28535575 | GDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in men |
| Q88983378 | GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD |
| Q36962726 | GDF15 contributes to radiation-induced senescence through the ROS-mediated p16 pathway in human endothelial cells |
| Q41198863 | GDF15 is a heart-derived hormone that regulates body growth |
| Q42373707 | Growth Differentiation Factor 15 Is Associated With Major Amputation and Mortality in Patients With Peripheral Artery Disease |
| Q33682931 | Growth Differentiation Factor-15 Deficiency Augments Inflammatory Response and Exacerbates Septic Heart and Renal Injury Induced by Lipopolysaccharide |
| Q64945080 | Growth Differentiation Factor-15 Levels at Admission Provide Incremental Prognostic Information on All-Cause Long-term Mortality in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention. |
| Q52632771 | Growth differentiation factor 15 impairs aortic contractile and relaxing function through altered caveolar signaling of the endothelium. |
| Q95338257 | Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player |
| Q40396855 | Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction |
| Q57448663 | Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial |
| Q57822526 | Impact of Left Ventricular Diastolic Dysfunction and Biomarkers on Pulmonary Hypertension in Patients with Severe Aortic Stenosis |
| Q39903699 | Increased Serum Level of Growth Differentiation Factor 15 (GDF-15) is Associated with Coronary Artery Disease |
| Q47193481 | Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure. |
| Q93192737 | Metabolic remodeling induced by mitokines in heart failure |
| Q48165741 | Multibiomarker analysis in patients with acute myocardial infarction |
| Q37402807 | Multiplexed VeraCode bead-based serological immunoassay for colorectal cancer. |
| Q48156451 | Novel Biomarkers for the Risk Stratification of Heart Failure with Preserved Ejection Fraction |
| Q90662820 | Novel Biomarkers in Patients with Chronic Kidney Disease: An Analysis of Patients Enrolled in the GCKD-Study |
| Q33615459 | Novel biomarkers for cardiovascular risk prediction |
| Q90348298 | Pericardial fluid levels of growth differentiation factor 15 in patients with or without coronary artery disease: a prospective study |
| Q27027899 | State of the Art: Newer biomarkers in heart failure |
Search more.